טוען...
Protease inhibitor GC376 for COVID-19: Lessons learned from feline infectious peritonitis
The main protease (M(pro)) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an important therapeutic target as it plays a major role in the processing and maturation of the viral polyprotein. GC376 is a pre-clinical dipeptide-based protease inhibitor that has been previously used f...
שמור ב:
| הוצא לאור ב: | Ann Med Surg (Lond) |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7797473/ https://ncbi.nlm.nih.gov/pubmed/33456770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amsu.2020.12.030 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|